Dataset Information

Mono- and bis-tolylterpyridine iridium(III) complexes.

ABSTRACT: The first structure report of trichlorido[4'-(p-tolyl)-2,2':6',2''-terpyridine]iridium(III) dimethyl sulfoxide solvate, [IrCl(3)(C(22)H(17)N(3))] x C(2)H(6)OS, (I), is presented, along with a higher-symmetry setting of previously reported bis[4'-(p-tolyl)-2,2':6',2''-terpyridine]iridium(III) tris(hexafluoridophosphate) acetonitrile disolvate, [Ir(C(22)H(17)N(3))(2)](PF(6))(3) x 2 C(2)H(3)N, (II) [Yoshikawa, Yamabe, Kanehisa, Kai, Takashima & Tsukahara (2007). Eur. J. Inorg. Chem. pp. 1911-1919]. For (I), the data were collected with synchrotron radiation and the dimethyl sulfoxide solvent molecule is disordered over three positions, one of which is an inversion center. The previously reported structure of (II) is presented in the more appropriate C2/c space group. The iridium complex and one PF(6)(-) anion lie on twofold axes in this structure, making half of the molecule unique.

SUBMITTER: Hinkle LM

PROVIDER: S-EPMC2855593 | biostudies-literature | 2010 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Mono- and bis-tolylterpyridine iridium(III) complexes.

Hinkle Lindsay M LM Young Victor G VG Mann Kent R KR

Acta crystallographica. Section C, Crystal structure communications 20100203 Pt 3

The first structure report of trichlorido[4'-(p-tolyl)-2,2':6',2''-terpyridine]iridium(III) dimethyl sulfoxide solvate, [IrCl(3)(C(22)H(17)N(3))] x C(2)H(6)OS, (I), is presented, along with a higher-symmetry setting of previously reported bis[4'-(p-tolyl)-2,2':6',2''-terpyridine]iridium(III) tris(hexafluoridophosphate) acetonitrile disolvate, [Ir(C(22)H(17)N(3))(2)](PF(6))(3) x 2 C(2)H(3)N, (II) [Yoshikawa, Yamabe, Kanehisa, Kai, Takashima & Tsukahara (2007). Eur. J. Inorg. Chem. pp. 1911-1919]. ...[more]

PMID: 20203396

Similar Datasets

Project description:Six homo- or heteroleptic tricationic Ir(R1-tpy)(R2-tpy)3+ complexes (Ir1-Ir6, R1/R2 = Ph, 4'-N(CH3)2Ph, pyren-1-yl, or 4'-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}Ph, tpy = 2,2';6',2"-terpyridine) were synthesized and tested for photodynamic therapy (PDT) effects. The ground- and excited-state characteristics of these complexes were studied systematically via spectroscopic methods and quantum chemistry calculations. All complexes possessed intraligand charge transfer (1ILCT) / metal-to-ligand charge transfer (1MLCT) dominated transition(s) in their low-energy absorption bands, which red-shifted with the increased electron-releasing strength of the R1/R2 substituent. Five of the complexes exhibited ligand-centered 3 π,π*/3ILCT/3MLCT emission. With a stronger electron-releasing R1/R2 substituent, the degree of charge transfer contribution increased, leading to a decrease of the emission quantum yield. When the 4'-N(CH3)2Ph substituent was introduced on both tpy ligands, the emission of Ir3 was completely quenched. Our study on the transient absorption of these complexes demonstrated that they all possessed broadband triplet excited-state absorption in the 400-800 nm region. Pyrenyl substitution of one or more tpy ligands, as in Ir4 and Ir5, increased the lifetimes of the lowest triplet excited state and the singlet oxygen (1O2) production efficiencies. Ir1-Ir5 were nontoxic toward SK-MEL-28 cells, with photocytotoxicities that varied from 0.18 to 153 µM. Among them, Ir4 had the highest 1O2 quantum yield (0.81) in cell-free conditions, showing the largest photocytotoxicity against SK-MEL-28 cells for Ir(III) PSs to date, and was the most efficient generator of reactive oxygen species (ROS) in vitro. Ir4 possessed a very large phototherapeutic index (PI = dark EC50 / light EC50) of >1657, the largest reported for an Ir(III) complex photosensitizer upon broadband visible light (400-700 nm) activation. Ir4 also exhibited a very strong PDT effect toward MCF-7 breast cancer cells and its xenograft tumor model. Upon 450-nm light activation, Ir4 dramatically inhibited the xenograft tumor growth and exhibited negligible side effects upon PDT treatment.

Project description:Iridium(III) complexes have assumed a prominent role in the areas of photochemistry and photophysics due to the peculiar properties of both the metal itself and the ligand environment that can be assembled around it. Ir(III) is larger, heavier, and bears a higher ionic charge than its analogue and widely used d6 ions such as Fe(II) and Ru(II). Accordingly, its complexes exhibit wider ligand-field d-d orbital splitting with electronic levels centered on the metal, typically nonemissive and photodissociative, not playing a relevant role in excited-state deactivations. In other words, iridium complexes are typically more stable and/or more emissive than Fe(II) and Ru(II) systems. Additionally, the particularly strong heavy-atom effect of iridium promotes singlet-triplet transitions, with characteristic absorption features in the UV-vis and relatively short excited-state lifetimes of emissive triplet levels. Ir(III) is also a platform for anchoring ligands of rather different sorts. Its versatile chemistry includes not only coordination with classic N∧N neutral ligands but also the binding of negatively charged chelators, typically having a cyclometalating C∧N anchor. The carbon-metal bond in these systems has some degree of covalent character, but this does not preclude a localized description of the excited states of the related complexes, which can be designated as metal-centered (MC), ligand-centered (LC), or charge transfer (CT), allowing a simplified description of electronic and photophysical properties. The possibility of binding different types of ligands and making heteroleptic complexes is a formidable tool for finely tuning the nature and energy of the lowest electronic excited state of cationic Ir(III) complexes by ligand design. Herein we give an account of our work on several families of iridium complexes typically equipped with two cyclometalating bidentate ligands (C∧N), in combination with mono or bidentate "ancillary" ligands with N∧N, C∧N, and C∧C motifs. We have explored new synthesis routes for both cyclometalating and ancillary ligands, obtaining primarily cationic complexes but also some neutral or even negatively charged systems. In the domain of the ancillary ligands, we have explored isocyanides, carbenes, mesoionic triazolylidenes, and bis-tetrazolic ligands. For the cyclometalating moiety, we have investigated carbene, mesoionic triazolylidene, and tetrazolic systems. Key results of our work include new strategies to modify both cyclometalating and ancillary ligands by relocating ionic charges, the determination of new factors affecting the stability of complexes, a demonstration of subtle structural effects that strongly modify the photophysical properties, new options to get blue-greenish emitters for optoelectronic devices, and a set of ligand modifications allowing the optimization of electrochemical and excited-state properties to obtain new promising Ir(III) complexes for photoredox catalysis. These results constitute a step forward in the preparation of custom iridium-based materials crafted by excited-state engineering, which is achieved through the concerted effort of computational and synthetic chemistry along with electrochemistry and photochemistry.

Dataset Information

Mono- and bis-tolylterpyridine iridium(III) complexes.

Publications

Mono- and bis-tolylterpyridine iridium(III) complexes.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets